...
ixhl-img

Incannex Healthcare Ltd ADR, Common Stock

IXHL

NMQ

$1.665

+$0

(0%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$29.46M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
14.41K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.21
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.5 L
$8.47 H
$1.665

About Incannex Healthcare Ltd ADR, Common Stock

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate in Phase 2 clinical trial to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameIXHLSectorS&P500
1-Week Return-6.2%-1.57%0.77%
1-Month Return-30.43%-1.86%5.21%
3-Month Return-1.78%-6.07%10.43%
6-Month Return-45.61%-0.47%13.46%
1-Year Return-80.87%10%32.91%
3-Year Return-88.78%10.67%32.22%

Financials

Jun '20Jun '21Jun '22Jun '23Jun '245YR TREND
Total Revenue415.63K1.90M540.17K1.01M12.00K[{"date":"2020-06-30","value":21.9,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":28.47,"profit":true},{"date":"2023-06-30","value":53.43,"profit":true},{"date":"2024-06-30","value":0.63,"profit":true}]
Cost of Revenue309.44K911.97K4.38K--[{"date":"2020-06-30","value":33.93,"profit":true},{"date":"2021-06-30","value":100,"profit":true},{"date":"2022-06-30","value":0.48,"profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Gross Profit106.19K985.63K535.79K1.01M12.00K[{"date":"2020-06-30","value":10.47,"profit":true},{"date":"2021-06-30","value":97.21,"profit":true},{"date":"2022-06-30","value":52.85,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":1.18,"profit":true}]
Gross Margin25.55%51.94%99.19%100.00%100.00%[{"date":"2020-06-30","value":25.55,"profit":true},{"date":"2021-06-30","value":51.94,"profit":true},{"date":"2022-06-30","value":99.19,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Operating Expenses2.96M9.22M8.37M49.67M30.05M[{"date":"2020-06-30","value":5.95,"profit":true},{"date":"2021-06-30","value":18.57,"profit":true},{"date":"2022-06-30","value":16.86,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":60.51,"profit":true}]
Operating Income(2.89M)(8.24M)(7.84M)(49.67M)(30.04M)[{"date":"2020-06-30","value":-288565421,"profit":false},{"date":"2021-06-30","value":-823933700,"profit":false},{"date":"2022-06-30","value":-783669486,"profit":false},{"date":"2023-06-30","value":-4966800000,"profit":false},{"date":"2024-06-30","value":-3004100000,"profit":false}]
Total Non-Operating Income/Expense150.64K78.43K(2.44M)1.22M11.82M[{"date":"2020-06-30","value":1.27,"profit":true},{"date":"2021-06-30","value":0.66,"profit":true},{"date":"2022-06-30","value":-20.68,"profit":false},{"date":"2023-06-30","value":10.32,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Pre-Tax Income(2.70M)(8.16M)(10.29M)(48.81M)(18.43M)[{"date":"2020-06-30","value":-269988937,"profit":false},{"date":"2021-06-30","value":-816359000,"profit":false},{"date":"2022-06-30","value":-1028991200,"profit":false},{"date":"2023-06-30","value":-4881100000,"profit":false},{"date":"2024-06-30","value":-1842900000,"profit":false}]
Income Taxes488.28K(2.68K)(3.55M)-30.00K[{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":-0.55,"profit":false},{"date":"2022-06-30","value":-727.7,"profit":false},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":6.14,"profit":true}]
Income After Taxes(3.19M)(8.16M)(6.74M)-(18.46M)[{"date":"2020-06-30","value":-318817237,"profit":false},{"date":"2021-06-30","value":-816091100,"profit":false},{"date":"2022-06-30","value":-673667200,"profit":false},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":-1845900000,"profit":false}]
Income From Continuous Operations(3.93M)(8.16M)(21.67M)(19.98M)(18.46M)[{"date":"2020-06-30","value":-392928400,"profit":false},{"date":"2021-06-30","value":-816359000,"profit":false},{"date":"2022-06-30","value":-2166551444,"profit":false},{"date":"2023-06-30","value":-1997955800,"profit":false},{"date":"2024-06-30","value":-1845900000,"profit":false}]
Income From Discontinued Operations(768.35K)----[{"date":"2020-06-30","value":-76835200,"profit":false},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Net Income(3.23M)(8.16M)(10.29M)(48.81M)(18.46M)[{"date":"2020-06-30","value":-322783935,"profit":false},{"date":"2021-06-30","value":-816091100,"profit":false},{"date":"2022-06-30","value":-1028991200,"profit":false},{"date":"2023-06-30","value":-4881100000,"profit":false},{"date":"2024-06-30","value":-1845900000,"profit":false}]
EPS (Diluted)----(1.22)[{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":-122.26,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

IXHL
Current Ratio 1.65

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

IXHL
ROA (LTM) -56.97%
ROE (LTM) -115.22%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

IXHL
Debt Ratio Lower is generally better. Negative is bad. 0.59
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.41

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

IXHL
Trailing PE NM
Forward PE NM
P/S (TTM) 2454.85
P/B 4.47
Price/FCF NM
EV/R 305.14
EV/Ebitda NM

FAQs

What is Incannex Healthcare Ltd ADR share price today?

Incannex Healthcare Ltd ADR (IXHL) share price today is $1.665

Can Indians buy Incannex Healthcare Ltd ADR shares?

Yes, Indians can buy shares of Incannex Healthcare Ltd ADR (IXHL) on Vested. To buy Incannex Healthcare Ltd ADR from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IXHL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Incannex Healthcare Ltd ADR be purchased?

Yes, you can purchase fractional shares of Incannex Healthcare Ltd ADR (IXHL) via the Vested app. You can start investing in Incannex Healthcare Ltd ADR (IXHL) with a minimum investment of $1.

How to invest in Incannex Healthcare Ltd ADR shares from India?

You can invest in shares of Incannex Healthcare Ltd ADR (IXHL) via Vested in three simple steps:

  • Click on Sign Up or Invest in IXHL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Incannex Healthcare Ltd ADR shares
What is Incannex Healthcare Ltd ADR 52-week high and low stock price?

The 52-week high price of Incannex Healthcare Ltd ADR (IXHL) is $8.47. The 52-week low price of Incannex Healthcare Ltd ADR (IXHL) is $1.5.

What is Incannex Healthcare Ltd ADR price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Incannex Healthcare Ltd ADR (IXHL) is

What is Incannex Healthcare Ltd ADR price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Incannex Healthcare Ltd ADR (IXHL) is 4.47

What is Incannex Healthcare Ltd ADR dividend yield?

The dividend yield of Incannex Healthcare Ltd ADR (IXHL) is 0.00%

What is the Market Cap of Incannex Healthcare Ltd ADR?

The market capitalization of Incannex Healthcare Ltd ADR (IXHL) is $29.46M

What is Incannex Healthcare Ltd ADR’s stock symbol?

The stock symbol (or ticker) of Incannex Healthcare Ltd ADR is IXHL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top